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ABSTRACT
Objective: Robotic technology has been used in a variety
of surgical procedures for its 3D magnification and preci-
sion. Minimally invasive techniques have already become
common in neurosurgery; however, robotic-assisted pro-
cedures in neurosurgery are still a relatively new frontier.
This report describes the first use of robotic technology to
resect a left thoracolumbar neurofibroma.
Case Report: A 19-year-old male with a family history of
neurofibromatosis was diagnosed with a suspected 3-cm x
4-cm neurofibroma in the T12-L1 left paraspinal area. His
only complaint was back pain requiring narcotic analge-
sics. He had no other findings on physical examination or
laboratory/radiologic workup.
Methods: After consulting urologic robotic surgeons, it
was agreed to use the da Vinci robot (Intuitive Surgical,
Sunnyvale, CA) for the resection of this mass. Following
retroperitoneal laparoscopic access, the urologic surgeons
opened the diaphragm and began the initial mobilization
of the mass laparoscopically. The robot was docked, and
the neurosurgeon operated the robot at the console to
resect the mass from its nerve origin. There were no
complications, and the mass, a confirmed neurofibroma,
was completely removed. The patient was discharged on
postoperative day 2; his back pain resolved, requiring no
analgesia by the end of the first postoperative week.
Conclusion: This case provides early evidence that ro-
botic assistance can be successfully used for the resection
of a paraspinal neurofibroma.
Key Words: Neurofibroma, Retroperitoneal, Robotic-As-
sisted, Laparoscopic, Thoracolumbar, Transdiaphrag-
matic.
INTRODUCTION
Neurofibromatosis-1 (NF-1) is an autosomal dominant disor-
der with an incidence of almost 1 in 3000; overall, 50% of
patients have a family history consistent with this disorder.1
The major features include multiple neural tumors (neurofi-
bromas), numerous pigmented skin lesions (which may in-
clude cafe ´ au lait spots), and pigmented hamartomas affect-
ing the iris (Lisch nodules). Approximately, 95% of these
patients will develop cutaneous or subcutaneous neurofibro-
mas, and 30% will develop plexiform neurofibromas.1 Lapa-
roscopic removal of retroperitoneal neurofibromas has been
described in only 3 patients.2,3 The 12X magnification af-
forded by the laparoscope appeared to facilitate the careful
dissection around the nerves.
Recently, the da Vinci surgical robot has entered the sur-
gical realm, most notably in urology for the surgical treat-
ment of prostate cancer. The 6 degrees of freedom af-
forded by the robot instrumentation, combined with the
3D high-definition image, and rock steady operating arms,
allow the surgeon to operate in an extremely precise,
meticulous manner heretofore unavailable. In addition,
the magnification provided by the endoscope varies from
12X to 40X depending on its proximity to the target tissue.
Application of this technology for excision of a neurofi-
broma has appeared in the literature on only one occa-
sion: in 2003, a mediastinal neurofibroma was removed by
cardiothoracic surgeons using a totally endoscopic ap-
proach with three 1-cm incisions for the robotic ports.4
Herein, we report the first case of a robotic-assisted lapa-
roscopic resection of a thoracolumbar neurofibroma via a
retroperitoneoscopic laparoscopic approach, making it
the first case of a paraspinal tumor removed robotically.
CASE REPORT
A 19-year-old male with a history of neurofibromatosis
type I presented with a 2-year history of back pain
located on the left side of his thoracolumbar paraspinal
area with no radiation. The pain progressively wors-
ened over 2 years increasing significantly the 2 months
prior to presentation resulting in the use of narcotic
analgesia.
The patient had a past medical history positive for a
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CASE REPORTmelanoma, which was excised from his back 3 months
before presentation. Family history revealed the patient’s
mother has a diagnosis of NF-1, and a history of multiple
tumors including neurofibromas and a melanoma.
Physical examination revealed a slender Caucasian male
(59”, 153 pounds), with multiple pigmented nevi on his
skin. He had a 3-cm x 3-cm scar in the left mid/upper back
area lateral to his spine, where his melanoma had been
excised. He had some left costovertebral angle tender-
ness. The remainder of his physical examination, includ-
ing a detailed neurological evaluation, was unremarkable.
CT angiography showed a 4.3-cm x 2.9-cm paravertebral
mass at the T12-L1 junction, with a slightly widened neural
foramen. The mass appeared adjacent to the upper pole of
the kidney, albeit posterior to the inferior left hemidia-
phragm. An MRI of the chest revealed a 3.7-cm x 3.0-cm
lobulated paraspinal mass at T12-L1 posterior to the upper
pole of the left kidney. MRI scan of the thoracic spine with
and without contrast revealed the mass to be arising from
a widened neural foramen at T12-L1 with no extension
into the spinal canal with the mass projecting laterally
behind the left kidney and posteriorly into paraspinal
muscles. The mass enhanced uniformly with contrast,
consistent with a neurofibroma (Figures 1, 2).
Spinal angiography revealed the dual supply of the infe-
rior spinal cord by 2 origins of the artery of Adamkiewicz,
at both T10 and L2 on the left.
Surgical excision of the mass was offered for pain relief
and diagnosis. Both standard open and minimally invasive
procedures were discussed. Because of the extraspinal
retrophrenic/retrorenal location of the mass, a minimally
invasive approach was chosen. Urology was consulted
regarding the feasibility of accessing the tumor via a ret-
roperitoneal laparoscopic approach and the possibility of
using the da Vinci robot (Intuitive Surgical, Sunnyvale,
CA) for tumor excision. After extensive discussion of the
risk and benefits with the patient and his family, the
minimally invasive robotic approach was selected with
full knowledge of a possible conversion to a standard
open approach.
Operative Procedure
With the patient prepared and draped in a right lateral
decubitus position, a 12-mm incision was made off of the
tip of the twelfth rib. A Veress needle was then used to
insufflate the retroperitoneum. An Ethicon X-Cel 12-mm
optical port (Ethicon, Somerville, NJ) was placed under
direct endoscopic control into the pneumoretroperito-
neum. The retroperitoneum was further expanded by us-
ing a dissection balloon (U. S. Surgical Inc., Norwalk, CT).
Two 8-mm robotic ports were then placed subcostally,
one in the posterior axillary line, and the other in the
anterior axillary line (Figure 3). A 12-mm port was placed
above the iliac crest in the anterior axillary line, and a
5-mm port was placed just above and medial to it.
The psoas muscle was identified and dissected medially
and superiorly, until the diaphragm was noted. The kid-
ney, within Gerota’s fascia, was mobilized along its pos-
terior surface and retracted medially. Careful inspection of
the retroperitoneum then revealed the mass, pushing the
diaphragm upward. The diaphragm was incised vertically
over the mass, and the anterior surface of the mass was
dissected until its upper and lower margin could be clearly
discerned (Figure 4).
The da Vinci robot was then docked (Figure 3). The
neurosurgeon then sat at the robotic console, while the
urologic surgeon assisted at the side of the operating
table. The robotic endoscope (12 mm) and 2 robotic arms
(8 mm) were placed through the aforedescribed ports.
Bipolar serrated graspers were placed in the left robotic
hand, and monopolar electrosurgical scissors were placed
in the right robotic hand. The tumor capsule was coagu-
lated with the bipolar graspers and incised with the acti-
vated scissors. The tumor capsule was extremely thin and
friable; however, the tumor was not soft enough to be
removed with suction. In this fashion, an intracapsular
tumor debulking was accomplished, with the resected
Figure 1. Abdominal CT scan revealing paravertebral mass (black
arrow) adjacent to the upper pole of the left kidney, posterior to the
inferior left hemidiaphragm (white curve and arrow).
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suction operated by the urologic surgeon. After removing
one third of the tumor, enough space was made to elevate
the posterior aspect of the tumor revealing the tumor
attachment to its nerve root of origin (Figure 5). The
nerve was coagulated and transected, freeing the remain-
ing, which was placed into an entrapment sack. A frozen
section analysis confirmed the diagnosis of neurofibroma.
Fibrin glue was placed over the nerve root to prevent
leakage of cerebral spinal fluid.
Figure 2. T1-weighted MRI of mass originating at T12-L1 neural foramen.
Figure 3. Docked robot, with 2 working arms, one arm attached
to the endoscope, and 2 additional assistant’s ports.
Figure 4. Initial view of tumor through robotic endoscope with
bipolar serrated graspers in the left robotic hand, monopolar
electrosurgical scissors in the right robotic hand, and assistant
operated irrigation/suction inferiorly.
Retroperitoneal Transdiaphragmatic Robotic-Assisted Laparoscopic Resection of a Left Thoracolumbar Neurofibroma, Moskowitz RM et al
JSLS (2009)13:64–68 66A small pleurotomy occurred during the tumor resection;
to evacuate the pneumothorax, a 10F Cope loop thora-
costomy tube was placed percutaneously into the left
hemithorax. The robot was used to close the pleurotomy
with a running 4–0 chromic suture; the diaphragm was
closed using silk suture and Lapra-Ty clips.
The total operative time was 5.3 hours, of which approx-
imately 2 hours was robotic console time. The estimated
blood loss was less than 50 mL. A postoperative chest
x-ray in the postanesthesia care unit showed no pneumo-
thorax. The chest tube was removed in the postanesthesia
care unit, and repeat chest x-rays confirmed no pneumo-
thorax had developed.
The patient was discharged home on postoperative day 2;
there were no focal neurological deficits. While recover-
ing in the hospital, the patient’s pain was controlled with
oral morphine CR (30 mg), given every 8 hours for a total
of 7 doses. He was also given his usual dose of gabapentin
(200 mg, 3 times a day). At discharge, the patient was
given hydrocodone/acetaminophen (5/500) to be taken
orally as needed every 4 hours for pain, and morphine CR
(30 mg) to be taken orally as needed every 12 hours for
pain for up to 1 week.
Pathological examination of the operative specimen
showed it to be a neurofibroma, composed of stellate and
spindle-shaped cells in a loose connective tissue matrix
containing stout collagen fibers and rare entrapped axons
(Figure 6).
At the patient’s 1-week postoperative office visit, his pain
had completely resolved. He was back to normal activity,
and he had discontinued taking pain medications. No
focal sensory or motor deficits were found on neurologi-
cal examination, though the patient reported an area of
numbness measuring2x3inches in his left thoracolum-
bar area.
DISCUSSION
Neurofibromatosis type I (NF-1), known as Von Reckling-
hausen disease, is an autosomal dominant disorder carried
on chromosome 17. The incidence has been measured to
be approximately 1 in every 3000 births.1 Besides the
previously described identifying characteristics of NF-1
(neurofibromas, pigmented skin lesions, and Lisch nod-
ules), it has the potential for multiple tumors (approxi-
mately 20% of NF patients)5 and the development of
malignancies that have the greatest impact on quality and
length of life.
Average length of life for patients with NF-1 has been
determined by a retrospective chart review to be 54.1
years, compared with 70.1 years for the general popula-
tion.1 Patients with neurofibromatosis type 1 were 1 time
to 2 times more likely to have a malignant neoplasm at the
time of death than the unaffected population; overall 2%
to 16% of patients with neurofibromas develop neural
sheath malignancies.1 Although there is no proven link
between neurofibromatosis and melanoma, there have
been almost 30 cases of melanoma reported in patients
with neurofibromatosis.6 Optic gliomas develop in 15% of
patients; however, only 2% to 5% are symptomatic.1
Figure 5. Retraction of tumor anteromedially after resection,
showing tumor bed and nerve root.
Figure 6. Neurofibroma histology, showing the presence of
stout collagen strands within the tumor. This has been referred to
as a “shredded carrot” appearance.
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been a focus of neurosurgical procedures and has been
the impetus for microsurgical techniques.7 In this regard,
robotic technology may prove to be an invaluable tool for
applying minimally invasive techniques for tissue and
nerve-sparing purposes.
The current da Vinci system supplies the surgeon with 4
robotic arms, one of which controls the high-definition,
full color, 3-D magnified endoscope. The surgeon’s move-
ments are translated to the robotic arm movements with-
out any noticeable delay and with up to 1:5 motion scal-
ing; the robotic arms have 6 degrees of freedom. Also
important, especially in the realm of neurosurgery, is the
ability of the robot computer to automatically eliminate
any surgeon hand tremor and provide the surgeon with a
540° wrist action.
In this young patient with a high risk of eventually requir-
ing additional surgeries, we thought that a minimally in-
vasive approach would be advantageous over an open
procedure, as it would allow faster recovery and small
incisions. Laparoscopic success of a retroperitoneal resec-
tion of a neurofibroma has already been reported in 3
separate cases; however, only one case was done with a
pure laparoscopic approach, as was ours for the initial
dissection, while the other 2 utilized a hand-assisted tech-
nique.2,3
The combination of the pure laparoscopic approach and
the latest in robotic technology enabled us to complete
the first successful robotic removal of a spinal tumor with
minimal resulting morbidity, a brief hospital stay, and
rapid postoperative recovery. We believe that the advent
of robotic technology will prove to be a boon to the
neurosurgeon. For the first time, the surgeon will be
afforded an absolutely stable tremor-free working plat-
form endowed with 6 degrees of freedom and a 540° wrist
with up to 1:5 motion scaling. The last will afford the
surgeon the ability to make the finest of movements in a
highly controlled manner. Also, the endoscopic view with
its 3D and high definition attributes provides an astound-
ing image that can provide magnification in the 12X to 40X
range. Lastly, and certainly not least, the ergonomic sur-
geon’s console provides the surgeon with a seated work-
ing environment, free of gown, gloves, and mask, that
provides a level of surgeon comfort, heretofore not pos-
sible.
CONCLUSION
Robotic-assisted laparoscopic resection of a retroperito-
neal paraspinal neurofibroma was successfully completed
for the first time. Further and more extensive applications
of the da Vinci robot system within the field of neurosur-
gery await.
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